Načítá se...

FGF18 as a prognostic and therapeutic biomarker in ovarian cancer

High-throughput genomic technologies have identified biomarkers and potential therapeutic targets for ovarian cancer. Comprehensive functional validation studies of the biological and clinical implications of these biomarkers are needed to advance them toward clinical use. Amplification of chromosom...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wei, Wei, Mok, Samuel C., Oliva, Esther, Kim, Sung-hoon, Mohapatra, Gayatry, Birrer, Michael J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3784549/
https://ncbi.nlm.nih.gov/pubmed/24018557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI70625
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!